UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

'DURVIT': a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment

BMC cancer, 2018-09, Vol.18 (1), p.888-888, Article 888

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of PD-1 blockade in cervical cancer is related to a CD8 + FoxP3 + CD25 + T-cell subset with operational effector functions despite high immune checkpoint levels

Journal for immunotherapy of cancer, 2019-02, Vol.7 (1), p.43-43, Article 43

2019

Link zum Volltext

Verfügbarkeit prüfen

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification

European journal of cancer (1990), 2017-06, Vol.78, p.82-90

2017

Link zum Volltext

Verfügbarkeit prüfen

Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy

Gynecologic oncology, 2024-08, Vol.187, p.113-119

2024

Link zum Volltext

Verfügbarkeit prüfen

[ 18 F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer

BMC cancer, 2024-04, Vol.24 (1), p.513-513, Article 513

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of pelvic exenteration for gynecologic malignancies

Gynecologic oncology, 2023-04, Vol.171, p.114-120

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

British journal of cancer, 2008-01, Vol.98 (1), p.80-85

2008

Link zum Volltext

Verfügbarkeit prüfen

Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?

Gynecologic oncology, 2022-08, Vol.166 (2), p.284-291

2022

Link zum Volltext

Verfügbarkeit prüfen

Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients

Gynecologic oncology, 2017-08, Vol.146 (2), p.380-385

2017

Link zum Volltext

Verfügbarkeit prüfen

Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands

Gynecologic oncology, 2016-06, Vol.141 (3), p.524-530

2016

Link zum Volltext

Verfügbarkeit prüfen

The clinical trail of TRAIL

European journal of cancer (1990), 2006-09, Vol.42 (14), p.2233-2240

2006

Link zum Volltext

Verfügbarkeit prüfen

Granulosa cell tumors of the ovary: The clinical value of serum inhibin A and B levels in a large single center cohort

Gynecologic oncology, 2007-05, Vol.105 (2), p.365-372

2007

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification” [Eur J Cancer 78 (2017) 82–90]

European journal of cancer (1990), 2017-10, Vol.84, p.370-370

2017

Link zum Volltext

Verfügbarkeit prüfen

409 Performance of DNA methylation analysis in urine, cervicovaginal self-samples and cervical scrapes for endometrial cancer detection

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A91-A92

2021

Link zum Volltext

Verfügbarkeit prüfen

401 Clinical evaluation of DNA methylation and HPV DNA testing in urine for cervical intraepithelial neoplasia and cervical cancer detection

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A24-A24

2021

Link zum Volltext

Verfügbarkeit prüfen

EP424 Validation of the new FIGO 2018 staging system in clinically early cervical cancer

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A275-A276

2019

Link zum Volltext

Verfügbarkeit prüfen

P57 Value of circulating tumor DNA in the differentiation between malignant and benign ovarian tumors

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A92-A92

2019

Link zum Volltext

Verfügbarkeit prüfen

ROLE OF ADJUVANT THERAPY IN INTERMEDIATE-RISK CERVICAL CANCER PATIENTS - SCCAN STUDY SUB-ANALYSIS

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, Vol.32, p.A44

2022

Link zum Volltext

Verfügbarkeit prüfen

Hot flushes in breast cancer patients

Critical reviews in oncology/hematology, 2006, Vol.57 (1), p.63-77

2006

Link zum Volltext

Verfügbarkeit prüfen

THE IMPACT OF HOSPITAL SURGICAL VOLUME ON SURVIVAL IN EARLY-STAGE CERVICAL CANCER TREATED WITH RADICAL HYSTERECTOMY: A SUB-ANALYSIS OF THE SCCAN STUDY

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, Vol.32, p.A52

2022

Link zum Volltext

Verfügbarkeit prüfen

VALIDATION OF THE NEW FIGO 2018 STAGING SYSTEM IN CLINICALLY EARLY CERVICAL CANCER: EP424

International journal of gynecological cancer, 2019-11, Vol.29 ESGO Annual Meeting Abstracts, p.A275-A276

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase I dose escalation study off BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor I (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

British journal of cancer, 2008, Vol.98 (1), p.80-85

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 study with BIBW 2992, an irreversible dual tyrosine kinase inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) in a 2 week on 2 week off schedule

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3025-3025

2006

Link zum Volltext

Verfügbarkeit prüfen

Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington’s disease

Neuroscience, 2013-05, Vol.238, p.71-81

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(70)
Life Sciences & Biomedicine
(60)
Humans
(38)
Female
(28)
Oncology
(25)
Adult
(17)
Middle Aged
(17)
Obstetrics & Gynecology
(16)
Aged
(15)
Cervical Cancer
(15)
Male
(13)
Aged, 80 And Over
(11)
Biological And Medical Sciences
(11)
Cancer
(10)
Medical Sciences
(10)
Neoplasm Staging
(10)
Patients
(10)
Survival
(9)
Tumors
(9)
Uterine Cervical Neoplasms - Pathology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

'DURVIT': a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment

Efficacy of PD-1 blockade in cervical cancer is related to a CD8 + FoxP3 + CD25 + T-cell subset with operational effector functions despite high immune checkpoint levels

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification

Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy

[ 18 F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer

Clinical outcomes of pelvic exenteration for gynecologic malignancies

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?

Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients

Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands

The clinical trail of TRAIL

Granulosa cell tumors of the ovary: The clinical value of serum inhibin A and B levels in a large single center cohort

Corrigendum to “Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification” [Eur J Cancer 78 (2017) 82–90]

409 Performance of DNA methylation analysis in urine, cervicovaginal self-samples and cervical scrapes for endometrial cancer detection

401 Clinical evaluation of DNA methylation and HPV DNA testing in urine for cervical intraepithelial neoplasia and cervical cancer detection

EP424 Validation of the new FIGO 2018 staging system in clinically early cervical cancer

P57 Value of circulating tumor DNA in the differentiation between malignant and benign ovarian tumors

ROLE OF ADJUVANT THERAPY IN INTERMEDIATE-RISK CERVICAL CANCER PATIENTS - SCCAN STUDY SUB-ANALYSIS

Hot flushes in breast cancer patients

THE IMPACT OF HOSPITAL SURGICAL VOLUME ON SURVIVAL IN EARLY-STAGE CERVICAL CANCER TREATED WITH RADICAL HYSTERECTOMY: A SUB-ANALYSIS OF THE SCCAN STUDY

VALIDATION OF THE NEW FIGO 2018 STAGING SYSTEM IN CLINICALLY EARLY CERVICAL CANCER: EP424

A phase I dose escalation study off BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor I (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

Phase 1 study with BIBW 2992, an irreversible dual tyrosine kinase inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) in a 2 week on 2 week off schedule

Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial

Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington’s disease

Suchergebnisse filtern